Aktie A0M4GL QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Qinghai Spring Medicinal Resources Technology Co., Ltd.

Aktien

A0M4GL

CNE0000017W0

600381

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 06.05.2024 		% 5 Tage % 1. Jan.
4.31 CNY -5.07% Intraday Chart für Qinghai Spring Medicinal Resources Technology Co., Ltd. -5.07% -44.24%
29.04. Qinghai Spring Medicinal Resources Technology Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
22.04. Qinghai Spring Medicinal Resources Technology Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Qinghai Spring Medicinal Resources Technology Plans Shares Buyback of Up to 50 Million Yuan
Qinghai Spring Medicinal Resources Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Qinghai Spring Medicinal Resources Technology Co., Ltd. authorizes a Buyback Plan.
Qinghai Spring Medicinal Resources Probed Over Misleading Ad for Rice Wine
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) added to S&P Global BMI Index
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
The 'Duos-activation' Healthy Brewing Theory of Qinghai Spring's Tinghua Liquor Gains International Recognition, FDA and TTB Have Authorized Its Overseas Product to Be Sold in the United States
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
WIPO Published an International Patent Application From Qinghai Spring's Tinghua Liquor: Will Improve People's Relationship With Alcohol and Reshape Distilled Spirits' Value Proposition
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Beijing Life Capital Management Co., Ltd. completed the acquisition of a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd.
Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million.
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4GL Aktie
  4. Nachrichten Qinghai Spring Medicinal Resources Technology Co., Ltd.
  5. Andere Sprachen